Skip to content
44

cortison nasenspray

Skip it

Soft demand (-26.8% this quarter) — this niche doesn't clear our bar today.

Market size 25Growth 12Conversion 94Competition 27Returns 100Price range 51Avg price 54Brand share 33Review moat 66Quality gap 32

Returns

Incredible0.0%

return rate — above 6% kills the launch gate

Conversion

Great11.7%

search→purchase rate — share of searches ending in a sale

Review moat

Good854.44

avg incumbent reviews — the moat a new listing must climb

Avg price

Good€12.42

avg listing price — sweet spot $15–$100

Price range

Good€6.98–€23.24

cheapest to priciest tracked listing — scored on the share inside $15–$100

Brand share

Okay85%

top-5 brand share — brands hold most of the demand

Quality gap

Okay4.6★

avg incumbent rating — lower means beatable quality

Competition

Okay69%

top-5 click share — leaders hold, buyers still browse

Market size

Okay€100K

€100K/yr · 69K searches

Growth

Bad-26.8%

90-day search growth — must beat 0% to launch

Competition

The top 5 products take 69% of clicks — established leaders, but buyers still shop beyond them.

Brands

11 falling

Sellers

28

Top-5 brand share

85%

Open market

9%

  • ratiopharm23%
  • MOMETAHEXAL23%
  • GALENpharma GmbH18%
  • IUSOT11%
  • ADGC10%
  • Bodfeld Apotheke6%
  • Open — no brand owns it (5 brands, 9%)

Product shelf

Each bubble is one product — market share against review moat; bubble size tracks estimated sales, color grades how beatable the incumbent looks.

0%5%€5K10%€10K15%€15K20%€20K1101001K10K Reviews — right = deep review moat Market share (90d) ≈ est. sales
Beatable (≤4.3★) Contested Strong incumbent (>4.7★)

All 18 tracked products in this niche — three views at once, no toggling.

Demand & seasonality

Weekly Amazon search volume, last 84 weeks — -26.8% search growth over the last 90 days.
3K2KSpike '25Spike '26DecJanFebMarAprMayJunJulAugSepOctNovDecJanFebMarAprMayJun

Peak months: Mar · busiest ÷ quietest = 2.2×

Reviews

What buyers praise and complain about, mined from review topics.

What buyers love

Sinus-Entlastung29%

“Nasallergra ist klasse”

Allergien19%

“Allergienasenspray”

Effizienz14%

“Hilft sehr gut”

Hustenlinderung14%

“Nach Jahren habe ich etwas gegen Heuschnupfen gefunden”

Preis-Leistungs-Verhältnis7%

“Sehr gutes Produkt,bester Preis”

What buyers complain about

Dosierung25%

“Nach gut 2 Wochen Einnahme, wenig Besserung”

Komfort insgesamt17%

“Sehr unangenehm, löst Schmerzen aus”

Schmerzlinderung – insgesamt17%

“Sehr unangenehm, löst Schmerzen aus”

Top return reasons

Funktionalität insgesamt25%
Heizung25%
Alterseignung25%
Bitter13%
Mundhygiene13%